The Invisible Gas in Your Home
Why radon is the second leading cause of lung cancer and what you can do about it
Radon is a colorless, odorless, radioactive gas that forms naturally as uranium in soil and rock breaks down. It seeps through foundations and accumulates in homes — and most people have no idea it's there. It's the second leading cause of lung cancer after smoking, responsible for around 21,000 deaths per year in the United States alone [1]. The good news: a $15 test kit can tell you if your home has a problem, and it's fixable.
What Radon Is and Where It Comes From
Radon is a naturally occurring noble gas in the uranium decay chain. It's produced wherever uranium-containing rock and soil exist — which is practically everywhere, though concentrations vary enormously by geography. Granite-rich areas, the Midwest, and parts of the Mountain West tend to have the highest levels, but elevated radon has been found in homes in all 50 states.
Because radon is a gas, it migrates upward through soil and enters homes through:
- Cracks in foundations and concrete floors
- Gaps around pipes and cables entering the building
- Sump pits and floor drains
- Crawl spaces and porous construction materials
Once inside, radon can accumulate — especially in basements and ground-floor rooms with limited ventilation. When radon decays, it produces radioactive particles called radon progeny (polonium-218, lead-214, bismuth-214, polonium-214) that you inhale. These particles lodge in lung tissue and emit alpha radiation that damages DNA directly.
How Much Is Too Much?
The US EPA sets an action level of 4 picocuries per liter (pCi/L) — above this, remediation is recommended. The EPA also suggests considering action above 2 pCi/L. The average indoor level in US homes is about 1.3 pCi/L; outdoor air averages around 0.4 pCi/L. In Europe, the World Health Organization action level is 100 Bq/m³ (approximately 2.7 pCi/L).
There is no known safe threshold — the risk appears to be linear with no lower bound, meaning even modest elevations carry some increased risk [2]. But the practical risk jumps significantly above 4 pCi/L, where the EPA estimates that lifetime exposure increases lung cancer risk by about 7 per 1,000 people for non-smokers, and by 62 per 1,000 for smokers.
The Smoking-Radon Combination Is Particularly Dangerous
Radon and cigarette smoke don't just add — they multiply. Data from European pooling studies found that heavy smokers exposed to radon levels above 200 Bq/m³ had an odds ratio of 29.3 for lung cancer compared to non-smoking, low-radon households [2]. The two carcinogens amplify each other's damage to lung tissue. This means smokers living with elevated radon have an especially urgent reason to both quit and test their home.
How to Test Your Home
Testing is easy, affordable, and the only way to know your radon level:
Short-term tests (2–90 days): Charcoal canisters or alpha track detectors placed in the lowest livable area. Available at hardware stores for $15–30. Results come back by mail in 1–2 weeks.
Long-term tests (90+ days): Alpha track detectors give a better average that accounts for seasonal variation. More accurate than short-term tests for determining actual exposure.
Testing tips:
- Test the lowest level you regularly use (basement if you use it, ground floor if not)
- Close windows and doors 12 hours before and during a short-term test
- Don't test during unusually stormy weather
- Retest after any major renovation or sealing of the home
Reducing Radon Levels
If your home tests above 4 pCi/L, professional mitigation is highly effective:
Sub-slab depressurization (the gold standard): A pipe is drilled through the foundation and connected to a fan that draws radon from beneath the slab and vents it outside. Reduces levels by 50–99% in most homes. Cost: $800–2,500 depending on foundation type.
Crawl space mitigation: A sealed cover over the crawl space with a vent pipe and fan. Very effective for homes on crawlspaces.
Ventilation improvements: Heat recovery ventilators (HRVs) and improved basement ventilation can reduce levels modestly. Less reliable than active depressurization but helpful as a supplemental measure.
For new construction, radon-resistant techniques (passive pipes, sealed membranes) can be installed at low cost and make active mitigation easier if levels are still elevated.
Evidence Review
The European Collaborative Analysis
The foundational evidence for residential radon and lung cancer risk comes from a landmark collaborative analysis of 13 European case-control studies, pooling individual data from 7,148 lung cancer cases and 14,208 controls [1][2]. Led by Sarah Darby and colleagues, this study demonstrated a clear, statistically significant dose-response relationship: the excess relative risk of lung cancer increased by 8% (95% CI 3–16%) per 100 Bq/m³ increase in residential radon concentration [2].
Importantly, this relationship held even when the analysis was restricted to people living in homes with radon below 200 Bq/m³ — the range relevant to the majority of European households — confirming that the risk is not confined to extreme exposures. The dose-response was linear with no evidence of a threshold, consistent with the biological mechanism of alpha radiation and DNA damage.
Never-Smoker Data
A 2021 systematic review and meta-analysis by Cheng et al. specifically examined the association in never-smokers, analyzing pooled data from 2,341 never-smoker cases and 8,967 controls [3]. The adjusted excess relative risk per 100 Bq/m³ was 0.15 (95% CI 0.06–0.25), confirming that radon poses meaningful lung cancer risk independent of tobacco exposure. This is particularly significant because it closes the argument that the radon-lung cancer association is merely a proxy for smoking behavior.
Updated Meta-Analyses
A 2023 updated meta-analysis by Le Thi Nhu Ngoc et al. synthesized 55 case-control studies across multiple populations and found a pooled odds ratio of 1.38 (95% CI 1.19–1.60) for residential radon and lung cancer [4]. The analysis also found elevated risk for childhood leukemia (OR 1.43; 95% CI 1.19–1.72), suggesting that radon's ionizing radiation may cause broader hematological harm, though the evidence is less extensive than for lung cancer.
Overall Assessment
Ruano-Ravina et al.'s 2023 overview concludes that the evidence base for residential radon and lung cancer is now "solid and consistent," comparable to the evidence base for other well-established carcinogens [5]. Multiple large pooling studies, meta-analyses, and the known biological mechanism (alpha particle-induced DNA double-strand breaks) all converge on the same conclusion: residential radon is a genuine, modifiable cause of lung cancer.
Limitations in the literature: Most residential radon studies rely on a single radon measurement taken after cancer diagnosis, which may not accurately represent decades of prior exposure. Long-term retrospective exposure assessment is methodologically challenging. Additionally, most studies used fixed-location measurements rather than personal dosimetry, which introduces exposure misclassification. These factors likely lead to some underestimation of the true effect size, as misclassification bias tends to attenuate observed associations.
Practical confidence level: High. The evidence is among the stronger links in environmental epidemiology, supported by a clear mechanism, multiple independent datasets, and consistent dose-response relationships across different populations and countries.
References
- Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studiesDarby S, Hill D, Auvinen A, Barros-Dios JM, Baysson H, Bochicchio F, et al.. BMJ, 2005. PubMed 15613366 →
- Residential radon and lung cancer: detailed results of a collaborative analysis of individual data from 13 epidemiologic studies in EuropeDarby S, Hill D, Deo H, Auvinen A, Barros-Dios JM, Baysson H, et al.. Scandinavian Journal of Work, Environment and Health, 2006. PubMed 16538937 →
- Systematic review and meta-analysis of residential radon and lung cancer in never-smokersCheng ES, Egger S, Hughes S, Weber M, Steinberg J, Rahman B, et al.. European Respiratory Review, 2021. PubMed 33536262 →
- Human Health Impacts of Residential Radon Exposure: Updated Systematic Review and Meta-Analysis of Case-Control StudiesLe Thi Nhu Ngoc, Park D, Lee YC. International Journal of Environmental Research and Public Health, 2023. PubMed 36612419 →
- An overview on the relationship between residential radon and lung cancer: what we know and future researchRuano-Ravina A, Martin-Gisbert L, Kelsey K, Pérez-Ríos M, Candal-Pedreira C, et al.. Clinical and Translational Oncology, 2023. PubMed 37610496 →
Transparency
View edit historyEvery change to this page is tracked in version control. If you have conflicting research or think something is wrong, we want to hear about it.